MedPath

Pharmanest, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)

Not yet recruiting
Conditions
Metabolic Dysfunction-associated Steatotic Liver Disease
Interventions
Diagnostic Test: Digital Pathology FibroNest Phenotypic Fibrosis Composite Score (Ph-FCS)
First Posted Date
2024-07-09
Last Posted Date
2024-10-16
Lead Sponsor
PharmaNest, Inc
Target Recruit Count
1700
Registration Number
NCT06493253
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

Digital Pathology and AI for Liver Outcomes in MASLD

Not yet recruiting
Conditions
Metabolic Dysfunction-associated Steatotic Liver Disease
Interventions
Diagnostic Test: Digital Pathology FibroNest Phenotypic Fibrosis Composite Score (Ph-FCS)
First Posted Date
2024-04-03
Last Posted Date
2024-10-17
Lead Sponsor
PharmaNest, Inc
Target Recruit Count
1800
Registration Number
NCT06344364
Locations
🇭🇰

The Chinese University of Hong Kong, Sha Tin, Hong Kong

🇪🇸

Fundació de Recerca Clinic Barcelona, Barcelona, Spain

🇪🇸

University of Seville, Sevilla, Spain

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath